PRIMARY FALLOPIAN-TUBE ADENOCARCINOMA IN-SITU ASSOCIATED WITH ADJUVANT TAMOXIFEN THERAPY FOR BREAST-CARCINOMA

被引：13

作者：

SONNENDECKER, HEM

COOPER, K

KALIAN, KN

机构：

[1] UNIV WITWATERSRAND,S AFRICAN INST MED RES,SCH MED,SCH PATHOL,DEPT ANAT PATHOL,POB 1038,JOHANNESBURG 2000,SOUTH AFRICA

[2] UNIV WITWATERSRAND,JOHANNESBURG HOSP,DEPT OBSTET & GYNAECOL,JOHANNESBURG 2001,SOUTH AFRICA

来源：

GYNECOLOGIC ONCOLOGY | 1994年 / 52卷 / 03期

关键词：

D O I：

10.1006/gyno.1994.1069

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report the first case of primary fallopian tube adenocarcinoma in situ in a patient who had received antiestrogen tamoxifen as adjuvant therapy for breast carcinoma. Clinical and in vivo animal model studies, referable to the possible estrogen agonist effect of tamoxifen on the female genital tract, are also reviewed. (C) 1994 Academic Press, Inc.

引用

页码：402 / 407

页数：6

共 37 条

[1]

BANNATYNE P, 1981, DIAGN GYNECOL OBSTET, V3, P49

[2]

Benedett JI, 1992, GYNECOL ONCOL, P853

[3]

BOCCARDO F, 1981, ONCOLOGY, V38, P281, DOI 10.1159/000225571

[4] TERATOGENIC EFFECTS OF CLOMIPHENE, TAMOXIFEN, AND DIETHYLSTILBESTROL ON THE DEVELOPING HUMAN FEMALE GENITAL-TRACT [J].

CUNHA, GR ;

TAGUCHI, O ;

NAMIKAWA, R ;

NISHIZUKA, Y ;

ROBBOY, SJ .

HUMAN PATHOLOGY, 1987, 18 (11) :1132-1143

[5]

DENHAM JW, 1984, CANCER, V53, P166, DOI 10.1002/1097-0142(19840101)53:1<166::AID-CNCR2820530129>3.0.CO

[6]

2-B

[7]

DEWAARD F, 1982, CANCER EPIDEMIOL, P901

[8]

DODSON MG, 1970, OBSTET GYNECOL, V36, P935

[9]

FRIEDL A, 1989, CANCER RES, V49, P4758

[10]

GOTTARDIS MM, 1988, CANCER RES, V48, P812

← 1 2 3 4 →